Chester County News and Community Website
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced its financial results for the second quarter ended June 30, 2024, along with recent business highlights.
Context Therapeutics Shines Bright: Q2 Successes and Promising Future Read More
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) announced its financial results for the fiscal second quarter ended June 29, 2024, posting stable revenue but noting industry challenges and strategic …
Vishay Intertechnology’s Strategic Roadmap: Navigating Industry Challenges & Expansion Plans Read More
KING OF PRUSSIA, PA — Vertex, Inc. (NASDAQ: VERX) announced its financial results for the second quarter ended June 30, 2024, revealing robust performance and strategic acquisitions to bolster growth.
Vertex, Inc. Shines with Strong Financials and Strategic Growth Initiatives Read More
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) announced its second-quarter 2024 financial results and significant progress in its nomlabofusp development program.
Larimar Therapeutics Reports Q2 2024 Financial Results and Milestones Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced its financial results for the second quarter of 2024 and provided a corporate update. The company reported net revenue of $2.8 …
Aclaris Therapeutics Reports Q2 2024 Financial Results and Updates Read More
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced its financial results for the second quarter ending June 30, 2024. The company reported net sales of $14.6 million, driven by …
Madrigal Pharmaceuticals Reports Q2 2024 Financial Results and Provides Updates Read More
WILMINGTON, DE — Enovis™ Corporation (NYSE: ENOV) announced its financial results for the second quarter ending June 28, 2024. The company reported net sales of $525 million, reflecting a 23% …
Enovis Impresses with Strong Growth and Innovative Moves: A Buy Opportunity! Read More
WILMINGTON, DE — Ashland Inc. (NYSE: ASH) announced its third quarter fiscal year 2024 financial results, ending June 30, 2024. The company, which specializes in additives and specialty ingredients, reported …
Ashland’s Fiscal Report: Resilience Amid Market Shifts Read More
AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) announced robust financial results for the quarter ending June 30, 2024, showing a significant increase in worldwide net sales.
Globus Medical Reports Strong Q2 Results, Boosts Guidance Read More
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) reported a 29% increase in net revenue for the quarter ended June 30, 2024. The company highlighted progress in its …
Harmony Biosciences Reports Q2 Growth and Expands Pipeline Read More